23
Participants
Start Date
February 28, 2015
Primary Completion Date
September 5, 2016
Study Completion Date
November 16, 2021
Sirolimus combined with CP, MT and ZA
"Cyclophosphamide, Methotrexate and Sirolimus will be administrated orally. Zoledronic Acid will be administrated by infusion (IV).~Trial based on a dose escalating study design assessing two dose levels of sirolimus when prescribed in combination with metronomic cyclophosphamide (CP), methotrexate (MT) and zoledronic acid (ZA) followed by an expansion cohort once the MTD is established."
Institut Bergonié, Bordeaux
Centre Oscar Lambret, Lille
Centre Léon Bérard, Lyon
Lead Sponsor
Collaborators (1)
Reliable Cancer Therapies
INDUSTRY
Pfizer
INDUSTRY
Institut Bergonié
OTHER